Chelation therapy does not improve outcomes after heart attack.

A recent study presented at the American College of Cardiology's Annual Scientific Session found that chelation therapy, a treatment that removes toxic metals from the body, did not improve outcomes for people with diabetes who had suffered a heart attack. The study, called TACT2, aimed to replicate the results of a previous trial that suggested chelation reduced cardiovascular events after a heart attack. However, the TACT2 results did not show any difference in outcomes between those who received chelation therapy and those who received a placebo. The study's lead author, Gervasio A. Lamas, stated that chelation therapy is not effective as a therapy for post-heart attack patients in the U.S. and Canada. While the study's findings may not be relevant to these countries, they could be relevant to areas of the world where lead exposure is more common. [Extracted from the article]